Adverse Events of the Use of SGLT2 Inhibitors in Patients with Heart Failure: A Systematic Review and Meta-analysis
Mariana Feldner de Britto, Ana Luiza Miranda de Oliveira, Ricardo Simões, Nathalia Sernizon Guimarães, Janaine Cunha Polese & Alessandra Hubner de Souza · Journal of Advances in Medicine and Medical Research · 2024
Background: Sodium-glucose cotransporter 2 (iSGLT2) inhibitors are a class of medications used in the treatment of Heart Failure (HF) to prevent the development and worsening of the disease. Despite the benefits reported in the literature, it is essential to investigate its adver...
Open access
Research Article
10.9734/jammr/2024/v36i75486